# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number: k161251   
B. Purpose for Submission: New device   
C. Measurand: Amphetamines, Cocaine, and Oxazepam in urine   
D. Type of Test: Qualitative immunochromatographic assay   
E. Applicant: Hangzhou Clongene Biotech Co., Ltd.   
F. Proprietary and Established Names: Clungene Oxazepam Tests Clungene Amphetamine Tests Clungene Cocaine Tests

# G. Regulatory Information:

1. Regulation section: 21 CFR, 862.3170 Benzodiazepine Test System 21 CFR, 862.3100 Amphetamine Test System 21 CFR, 862.3250 Cocaine Test System

2. Classification: All Class II

3. Product codes: JXM, DKZ, DIO

4. Panel: 91- Toxicology

# H. Intended Use:

1. Intended use(s): See Indications for use below

2. Indication(s) for use:

CLUNGENE Amphetamine Tests are immunochromatographic assays for the qualitative determination of d-Amphetamine in human urine at cut-off concentration of $1 0 0 0 ~ \mathrm { { n g / m L } }$ . The tests are available in a Cassette format, a Cup format, a Dip Card format, and a Split Key Cup format.

The tests provide only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

CLUNGENE Cocaine Tests are immunochromatographic assays for the qualitative determination of Cocaine in human urine at cut-off concentration of $3 0 0 ~ \mathrm { { n g / m L } }$ . The tests are available in a Cassette format, a Cup format, a Dip Card format, and a Split Key Cup format.

The tests provide only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for

prescription use.

CLUNGENE Oxazepam Tests are immunochromatographic assays for the qualitative determination of Oxazepam in human urine at cut-off concentration of $3 0 0 ~ \mathrm { { n g / m L } }$ . The tests are available in a Cassette format, a Cup format, a Dip Card format, and a Split Key Cup format.

The test may yield preliminary positive results even when prescription drug Oxazepam is ingested, at prescribed doses; it is not intended to distinguish between prescription use or abuse of this drug. There is no uniformly recognized cutoff concentration level for Oxazepam in urine. The tests provide only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

3. Special conditions for use statement(s): For Over-The-Counter (OTC) use. For In Vitro Diagnostic Use only.   
4. Special instrument requirements: Not applicable, as the device is a visually-read single use device

# I. Device Description:

The CLUNGENE Amphetamine Tests, CLUNGENE Cocaine Tests, and CLUNGENE Oxazepam Tests are immunochromatographic assays that use a lateral flow system for the qualitative detection of d-Amphetamine, Cocaine and Oxazepam (target analytes) in human urine. The tests are available in Cassette, Dip Card, Cup, and Split Key Cup formats. The tests are the first step in a two-step process. The second step is to send the sample for laboratory testing if preliminary positive results are obtained.

# J. Substantial Equivalence Information:

1. Predicate device name(s):

The FIRST CHECK MULTI DRUG CUP Urine Test

2. Predicate 510(k) number(s):

k052115

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Predicate (k052115)</td><td rowspan=1 colspan=1>Candidate Device</td></tr><tr><td rowspan=1 colspan=1>Indication(s)for Use</td><td rowspan=1 colspan=1>For the qualitativedetermination of drugs ofabuse in human urine</td><td rowspan=1 colspan=1>Same (but the number ofdrugs detected is different)</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateralflowimmunochromatographic assaysbased on theprinciple of antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Type of test</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>SpecimenType</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>AMP 1000 ng/mL, COC 300ng/mL, BZO 300 ng/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Intended Users</td><td rowspan=1 colspan=1>Lay Users (Over the Counter)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Predicate (k052115)</td><td rowspan=1 colspan=1>Candidate Device</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Cup</td><td rowspan=1 colspan=1>Cup, cassette, dip card</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>Marijuana, Cocaine,Amphetamine,Methamphetamine, Ecstasy,Opiates, Phencyclidine,Benzodiazepines, Barbiturates,Methadone, TricyclicAntidepressants,and Oxycodone</td><td rowspan=1 colspan=1>Amphetamines, cocaine,oxazepam</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None referenced

# L. Test Principle:

The CLUNGENE Amphetamine Tests, CLUNGENE Cocaine Tests, and CLUNGENE Oxazepam Tests utilize lateral flow immunochromatographic technology based on the principle of competitive binding. Drugs, if present in concentrations below the cutoff level, will not saturate the binding sites of antibody coated particles in the device. The antibodycoated particles will then be captured by immobilized drug-specific conjugate and a colored line will appear in the test line region. The colored line will not form if the sample contains drug in excess of the cutoff level because the drug will saturate all the binding sites of the drug-specific antibody. Each strip in the device contains a procedural control that appears in the control line region indicating that the sample has migrated properly on the test strip.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

Precision study samples were prepared from negative urine samples spiked to nine different concentrations: $+ 1 0 0 \%$ , $+ 7 5 \% + 5 0 \%$ , $+ 2 5 \%$ , cut off, $- 2 5 \%$ , $- 5 0 \%$ , $- 7 5 \%$ and - $. 1 0 0 \%$ of the drug cutoff concentration for each drug. All sample concentrations were confirmed by GC/MS. All aliquots for testing were blind labeled by the same person who prepared the samples but who did not take part in sample testing. For each combination of analyte and format, three operators read 50 results at each of the nine concentrations, for a total of 1350 results per analyte per format. Results are summarized below.

Cassette Format   

<table><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>-100%cutoff</td><td rowspan=1 colspan=1>-75%cutoff</td><td rowspan=1 colspan=1>-50%cutoff</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cutoff</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Dip card Format   

<table><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>-100%cutoff</td><td rowspan=1 colspan=1>-75%cutoff</td><td rowspan=1 colspan=1>-50%cutoff</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>+100%cutoff</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>19-/31+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Easy Cup Format

<table><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>19-/31+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Split Key Cup   

<table><tr><td rowspan=1 colspan=1>AMP</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>20-/30+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>31-/19+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Cassette Format   

<table><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>30-/20+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Dip card Format   

<table><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Easy Cup Format

<table><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>31-/19+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Split Key Cup Format

<table><tr><td rowspan=1 colspan=1>COC</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>32-/18+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Cassette Format

<table><tr><td rowspan=1 colspan=1>OXAZ</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>22-/28+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>27-/23+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Dip card Format   

<table><tr><td rowspan=1 colspan=1>OXAZ</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Easy Cup Format   

<table><tr><td rowspan=1 colspan=1>OXAZ</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>28-/22+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>25-/25+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>21-/29+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

Split Key Cup Format   

<table><tr><td rowspan=1 colspan=1>OXAZ</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>25%cut off</td><td rowspan=1 colspan=1>50%cut off</td><td rowspan=1 colspan=1>75%cut off</td><td rowspan=1 colspan=1>100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>30-/20+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>23-/27+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

b. Linearity/assay reportable range:

Not applicable. These devices are for qualitative use only.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Procedural controls are included in the test strip and device. A colored line appearing in the control zone is considered as an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique. Control standards are not supplied with these tests; however, it is recommended that positive and negative controls be tested as a good laboratory practice to confirm the test procedure and to verify proper test performance. Users should follow local, state, and federal guidelines to run the external controls.

Device stability has been evaluated through accelerated and real-time studies. A transport simulation study was performed to test extreme shipping temperatures. Protocols and acceptance criteria were reviewed and found to be acceptable. The manufacturer claims that the devices are stable at $4 { - } 3 0 ~ ^ { \circ } \mathrm { C }$ for 24 months based on the accelerated stability study at $4 5 ^ { \circ } \mathrm { C } _ { \mathrm { i } }$ , real time stability determination at both $4 \mathrm { { } ^ { \circ } C }$ and $3 0 \mathrm { { } ^ { \circ } C }$ and transport simulation conditions at $- 2 0 \mathrm { { ^ \circ C } }$ and $4 0 \%$ .

d. Detection limit: See Precision/Reproducibility section in M.1.a above.

e. Analytical specificity:

Cross reactivity was evaluated by spiking the structurally similar compounds shown below into drug free urine. The concentrations specified below represent the lowest concentration tested that produced a positive result. Testing was performed as instructed in the package insert and three lots of each device were evaluated. No differences were seen between formats. Results are summarized below.

# Amphetamine

<table><tr><td rowspan=1 colspan=1>Potential cross-reactant</td><td rowspan=1 colspan=1>LowestConcentrationproducing a positiveresult (ng/ml)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>D - Amphetamine</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>L - Amphetamine</td><td rowspan=1 colspan=1>50000</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>D/L  Amphetamine</td><td rowspan=1 colspan=1>3000</td><td rowspan=1 colspan=1>33%</td></tr><tr><td rowspan=1 colspan=1>Phentermine</td><td rowspan=1 colspan=1>3000</td><td rowspan=1 colspan=1>33%</td></tr><tr><td rowspan=1 colspan=1>Hydroxyamphetamine</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>MDA</td><td rowspan=1 colspan=1>5000</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>MDMA</td><td rowspan=1 colspan=1>Negative at 100000</td><td rowspan=1 colspan=1>&lt; 1%</td></tr><tr><td rowspan=1 colspan=1>MDE</td><td rowspan=1 colspan=1>Negative at 100000</td><td rowspan=1 colspan=1>&lt; 1%</td></tr><tr><td rowspan=1 colspan=1>D-methamphetamine</td><td rowspan=1 colspan=1>Negative at 100000</td><td rowspan=1 colspan=1>&lt; 1%</td></tr><tr><td rowspan=1 colspan=1>L-methamphetamine</td><td rowspan=1 colspan=1>Negative at 100000</td><td rowspan=1 colspan=1>&lt; 1%</td></tr><tr><td rowspan=1 colspan=1>Ephedrine</td><td rowspan=1 colspan=1>Negative at 100000</td><td rowspan=1 colspan=1>&lt; 1%</td></tr><tr><td rowspan=1 colspan=1>Pseudoephedrine</td><td rowspan=1 colspan=1>Negative at 100000</td><td rowspan=1 colspan=1>&lt; 1%</td></tr></table>

# Cocaine

<table><tr><td rowspan=1 colspan=1>Potential cross-reactant</td><td rowspan=1 colspan=1>Highest Concentrationproducing a negativeresult (ng/ml)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cocaine HCl</td><td rowspan=1 colspan=1>780</td><td rowspan=1 colspan=1>38.5</td></tr><tr><td rowspan=1 colspan=1>Cocaethylene</td><td rowspan=1 colspan=1>12500</td><td rowspan=1 colspan=1>2.4</td></tr><tr><td rowspan=1 colspan=1>Ecgonine HCl</td><td rowspan=1 colspan=1>32000</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>Norcocaine</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>0.3</td></tr></table>

Oxazepam   

<table><tr><td rowspan=1 colspan=1>Potential cross-reactant</td><td rowspan=1 colspan=1>Highest Concentrationproducing a negativeresult (ng/ml)</td><td rowspan=1 colspan=1>% Cross Reactivity</td></tr><tr><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Alprazolam</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>150%</td></tr><tr><td rowspan=1 colspan=1>a-Hydroxyalprazolam</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>24%</td></tr><tr><td rowspan=1 colspan=1>Bromazepam</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>Chlordiazepoxide</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>Clobazam</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>300%</td></tr><tr><td rowspan=1 colspan=1>Clonazepam</td><td rowspan=1 colspan=1>800</td><td rowspan=1 colspan=1>37%</td></tr><tr><td rowspan=1 colspan=1>Clorazepate dipotassium</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>150%</td></tr><tr><td rowspan=1 colspan=1>Delorazepam</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>Desalkylflurazepam</td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>75%</td></tr><tr><td rowspan=1 colspan=1>Diazepam</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>150%</td></tr><tr><td rowspan=1 colspan=1>Estazolam</td><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>12%</td></tr><tr><td rowspan=1 colspan=1>Flunitrazepam</td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>75%</td></tr><tr><td rowspan=1 colspan=1>Midazolam</td><td rowspan=1 colspan=1>12500</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>Nitrazepam</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>300%</td></tr><tr><td rowspan=1 colspan=1>Norchlordiazepoxide</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>150%</td></tr><tr><td rowspan=1 colspan=1>Nordiazepam</td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>75%</td></tr><tr><td rowspan=1 colspan=1>Temazepam</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>300%</td></tr><tr><td rowspan=1 colspan=1>Triazolam</td><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>12%</td></tr><tr><td rowspan=1 colspan=1>D/L-Lorazepam</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20%</td></tr></table>

Potential interfering substances were evaluated by spiking the compounds below into drug free urine and urine with drug concentrations at $+ / - 2 5 \%$ of the cutoff. Each compound was spiked at $1 0 0 , 0 0 0 \mathrm { n g / m L }$ and tested on three lots of each device. No interference was detected.

<table><tr><td colspan="3">Amphetamine</td></tr><tr><td>4-Acetamidophenol</td><td>Diazepam</td><td>O-Hydroxyhippuric acid</td></tr><tr><td>(-)-Cotinine</td><td>Diclofenac</td><td>Oxalic acid</td></tr><tr><td>(-)-Isoproterenol</td><td>Diflunisal</td><td>Oxazepam</td></tr><tr><td>(-)-Y-Ephedrine</td><td>Digoxin</td><td>Oxolinic acid</td></tr><tr><td>(±)-Chlorpheniramine</td><td>Diphenhydramine</td><td>Oxycodone</td></tr><tr><td>(IR,2S)-(-)-Ephedrine</td><td>Doxylamine</td><td>Oxymetazoline</td></tr><tr><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Ecgonine hydrochloride</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Penicillin-G</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Pentazocaine</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Pentobarbital</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Fenfluramine</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Prednisolone</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Procaine</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chloralhydrate</td><td colspan="1" rowspan="1">L-Ephedrine</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">L-Phenylephrine</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Tetrahydrocortisone</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Thebaine</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Cocaine hydrochloride</td><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">Tolbutamine</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">Morphine-3-D-glucuronide</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">D-Norpropoxyphene</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">D-Propoxyphene</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">D/L-Octopamine</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">D/L-Propanolol</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">D/L-Thyroxine</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">D/L-Tyrosine</td><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">β-Estradiol</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Δ9-THC-COOH</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1"></td></tr></table>

<table><tr><td colspan="3" rowspan="1">Cocaine</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Oxazepam</td></tr><tr><td colspan="1" rowspan="1">(-)-Cotinine</td><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Oxolinic acid</td></tr><tr><td colspan="1" rowspan="1">(-)-P-Ephedrine</td><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Oxycodone</td></tr><tr><td colspan="1" rowspan="1">(±)-3,4-Methylenedioxyamphetamine</td><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Oxymetazoline</td></tr><tr><td colspan="1" rowspan="1">(±)-Brompheniramine</td><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td></tr><tr><td colspan="1" rowspan="1">(±)-Chlorpheniramine</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">(±)-Isoproterenol</td><td colspan="1" rowspan="1">Estrone-3-sulfate</td><td colspan="1" rowspan="1">Penicillin-G</td></tr><tr><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Ethyl-p-aminobenzoate</td><td colspan="1" rowspan="1">Pentobarbital</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">hydrochloride</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">hydrochloride(±)-3,4-Methylene-dioxymethamphetamine</td><td colspan="1" rowspan="1">Prednisolone</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">Procaine</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Promazine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Promethazine</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Quinidine</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Iproniazid</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Chloralhydrate</td><td colspan="1" rowspan="1">L-Ascorbic acid</td><td colspan="1" rowspan="1">Serotonin</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">L-Phenylephrine</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Temazepam</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Tetracycline</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3 (β-D-glucuronide)</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Thebaine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Morphine Sulfate</td><td colspan="1" rowspan="1">Tolbutamide</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Morphine-3-β-D-glucuronide</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">D-Norpropoxyphene</td><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">D-Propoxyphene</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">D-Pseudoephedrine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Trimipramine</td></tr><tr><td colspan="1" rowspan="1">D/L-Amphetamine Sulfate</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">D/L-Octopamine</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">D/L-Propranolol</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">D/L-Tryptophan</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">D/L-Tyrosine</td><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">β-Estradiol</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">β-Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td><td colspan="1" rowspan="2"></td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Oxalic acid</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Oxazepam</td></tr><tr><td colspan="1" rowspan="1">4-Acetamidophenol</td><td colspan="1" rowspan="1">D-Propoxyphene</td><td colspan="1" rowspan="1">Naproxen</td></tr><tr><td colspan="1" rowspan="1">(-)-cotinine</td><td colspan="1" rowspan="1">D-Pseudoephedrine</td><td colspan="1" rowspan="1">Niacinamide</td></tr><tr><td colspan="1" rowspan="1">(-)-Y-Ephedrine</td><td colspan="1" rowspan="1">D/L-Amphetamine</td><td colspan="1" rowspan="1">Nifedipine</td></tr><tr><td colspan="1" rowspan="1">(+)-3,4-Methylenedioxy-amphetamine</td><td colspan="1" rowspan="1">D/L-Octopamine</td><td colspan="1" rowspan="1">Norethindrone</td></tr><tr><td colspan="1" rowspan="1">(+)-3,4-Methylenedioxy-methamphetamine</td><td colspan="1" rowspan="1">D/L-Propranolol</td><td colspan="1" rowspan="1">Noscapine</td></tr><tr><td colspan="1" rowspan="1">(±)-Chlorpheniramine</td><td colspan="1" rowspan="1">D/L-Tryptophan</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td></tr><tr><td colspan="1" rowspan="1">(±)-Chlorpheniramine</td><td colspan="1" rowspan="1">D/L-Tyrosine</td><td colspan="1" rowspan="1">Oxalic acid</td></tr><tr><td colspan="1" rowspan="1">(±)-Isoproterenol</td><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Oxolinic acid</td></tr><tr><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">p-Hydroxy- methamphetamine</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Pentobarbital</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Phencyclidine</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">Ecgonine hydrochloride</td><td colspan="1" rowspan="1">Phenobarbital</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Ecgonine methylester</td><td colspan="1" rowspan="1">Phentermine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Phenylpropanolamine</td></tr><tr><td colspan="1" rowspan="1">Apormorphine</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">Serotonin (5-Hydroxytyramine)</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">Iproniazid</td><td colspan="1" rowspan="1">Sertraline</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Tetrahydrocortisone</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">1-Ascorbic Acid</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">L-Phenylephrine</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Chloralhydrate</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Tolbutamide</td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Tryptamine</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">Cocaine hydrochloride</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">β-Phenylethylamine</td></tr><tr><td colspan="1" rowspan="1">D-Norpropoxyphene</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1"></td></tr></table>

To evaluate the effect of specific gravity, twelve drug free urine samples with specific gravities ranging from 1.000-1.035 were spiked with each drug to $) \pm 2 5 \%$ of the cutoff values. Three lots of each device were used to test all samples.

To evaluate the effects of pH, a negative urine pool was aliquoted and the $\mathsf { p H }$ of each aliquot was adjusted to 4.00 to 9.00, in increments of $1 \mu \mathrm { H }$ unit. Three lots of each device were used to test all samples. The aliquots were then spiked with amphetamine, cocaine, or Oxazepam to concentrations $2 5 \%$ below and $2 5 \%$ above the cutoff concentrations.

The pH and specific gravity ranges tested did not affect the results from the device.

f. Assay cut-off:

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision section, M.1.a., above.

2. Comparison studies:

# a. Method comparison with predicate device:

Method comparison samples consisted of 80 clinical samples (40 negative and 40 positive) for each drug. The samples were masked and randomized by a person who prepared the samples and who didn’t take part in the sample testing. Operators were blinded to the sample identity. Each sample concentration of the drug was confirmed by GC-MS. The drug concentration ranges tested were as follows: drug-free, $\leq 5 0 \%$ cut-off, $- 5 0 \%$ cut-off to cut-off, Cut-off to $+ 5 0 \%$ cut-off, and $\ge 5 0 \%$ cut-off, for each drug.

The above samples were tested using one lot of each format of the devices. Twelve (three for each format) laboratory assistants performed the test following the instructions for use. The obtained results were compared to the GC/MS results. The results are summarized below:

# Amphetamine

Discordant Results with Amphetamine Cassette   

<table><tr><td rowspan=1 colspan=2>Cassette</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>CassetteViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>963</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>1037</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Discordant Results with Amphetamine Panel Dip   

<table><tr><td rowspan=1 colspan=2>PanelDip</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Panel DipViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>963</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>1037</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=2>Split- Key Cup</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS (lessthan-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

# Discordant Results with Amphetamine Split-Key Cup

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Split-Key CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>963</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Discordant Results with Amphetamine Easy Cup   

<table><tr><td rowspan=1 colspan=2>EasyCup</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Easy CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>963</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>963</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>952</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>1037</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>1005</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Cocaine

<table><tr><td rowspan=1 colspan=1>Cassette</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results with Cocaine Cassette   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>CassetteViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>284</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>284</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=2>PanelDip</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results with Cocaine Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Panel DipViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>296</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>284</td><td rowspan=1 colspan=1>Positive</td></tr></table>

<table><tr><td rowspan=1 colspan=2>Split Key Cup</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results with Cocaine Split-Key Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Split CupViewerResults</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>284</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=2>EasyCup</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results with Cocaine Easy Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Easy CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COC45</td><td rowspan=1 colspan=1>284</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COC35</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>COC66</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>COC66</td><td rowspan=1 colspan=1>307</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>COC35</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Oxazepam

Discordant Results with Oxazepam Cassette   

<table><tr><td rowspan=1 colspan=2>Cassette</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>CassetteViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>309</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=2>PanelDip</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results with Oxazepam Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Panel DipViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=2>Split- Key Cup</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegativeby GC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegativeby GC/MS(Between-50%and</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results with Oxazepam Split-Key Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Split CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>309</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>323</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Discordant Results for Oxazepam Easy Cup   

<table><tr><td rowspan=1 colspan=2>EasyCup</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>GC/MSresult</td><td rowspan=1 colspan=1>Easy CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>308</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>309</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>309</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>311</td><td rowspan=1 colspan=1>Negative</td></tr></table>

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable

c. Other clinical supportive data (when a. and $b$ . are not applicable):

A consumer study was performed at three testing sites with a total of 1680 test subjects, with diverse educational backgrounds representative of U.S. demographics. A total of 140 users tested each format of each analyte. The study was performed by spiking drug free urine sample pools with drug at concentrations of $0 \%$ , $2 5 \%$ , $50 \%$ , $7 5 \%$ , $12 5 \%$ , $1 5 0 \%$ , and $1 7 5 \%$ of each drug cutoff. Each participant received one blinded sample, one test device format, and one English language package insert for the device they were to test. The only instructions provided to users were the package inserts for the device being tested. Participants ranged in age from 21 to greater than 50 years of age. None of the participants had experience using drug testing products before.

Each person performed the test and filled out a questionnaire to evaluate the ease of use of the device. All of the users correctly answered the questions on the questionnaire and rated the clarity of the package insert as either “very clear” or “clear”. The participant test results were compared to GC/MS results and are summarized below.

Comparison between GC/MS and Lay Person Results for Amphetamine Cassette   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>d-AmphetamineConcentration by GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Amphetamine Dip Card   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>d-AmphetamineConcentration by GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Amphetamine Split-Key Cup   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>d-AmphetamineConcentration by GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Amphetamine Easy Cup   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>d-AmphetamineConcentration by GC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1750</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Cocaine Cassette   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Cocaine Concentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrectresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Cocaine Dip Card   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Cocaine Concentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Cocaine Split-Key Cup   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Cocaine Concentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Cocaine Easy Cup   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Cocaine Concentration byGC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Oxazepam Cassette   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Oxazepam Concentrationby GC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Oxazepam Dip Card   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Oxazepam Concentrationby GC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Oxazepam Split-Key Cup   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Oxazepam Concentrationby GC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for Oxazepam Easy Cup   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Oxazepam Concentrationby GC/MS (ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=2 colspan=1>Percentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>525</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not Applicable

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# R. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.